These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 27593687)
1. Antibody Based Therapies in Acute Leukemia. Shah NN Curr Drug Targets; 2017; 18(3):257-270. PubMed ID: 27593687 [TBL] [Abstract][Full Text] [Related]
8. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Plosker GL; Figgitt DP Drugs; 2003; 63(8):803-43. PubMed ID: 12662126 [TBL] [Abstract][Full Text] [Related]
9. The past and future of CD33 as therapeutic target in acute myeloid leukemia. Laszlo GS; Estey EH; Walter RB Blood Rev; 2014 Jul; 28(4):143-53. PubMed ID: 24809231 [TBL] [Abstract][Full Text] [Related]
10. [The role of gemtuzumab ozogamicin in the treatment of acute myeloid leukemia patients]. Sakamaki H Gan To Kagaku Ryoho; 2008 Sep; 35(9):1629-34. PubMed ID: 18799927 [TBL] [Abstract][Full Text] [Related]
11. Trials with gemtuzumab ozogamicin (Mylotarg) combined with chemotherapy regimens in acute myeloid leukemia. Stadtmauer EA Clin Lymphoma; 2002 Mar; 2 Suppl 1():S24-8. PubMed ID: 11970767 [TBL] [Abstract][Full Text] [Related]
12. Antibody-based therapy for acute myeloid leukemia: a review of phase 2 and 3 trials. Thomas X; Elhamri M; Deloire A; Heiblig M Expert Opin Emerg Drugs; 2022 Jun; 27(2):169-185. PubMed ID: 35749672 [TBL] [Abstract][Full Text] [Related]
14. Novel monoclonal antibody-based therapies for acute myeloid leukemia. Morsink LM; Walter RB Best Pract Res Clin Haematol; 2019 Jun; 32(2):116-126. PubMed ID: 31203993 [TBL] [Abstract][Full Text] [Related]
15. Progress and Innovations in the Management of Adult Acute Lymphoblastic Leukemia. Jabbour E; Pui CH; Kantarjian H JAMA Oncol; 2018 Oct; 4(10):1413-1420. PubMed ID: 29931220 [TBL] [Abstract][Full Text] [Related]
16. The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia. Horvat TZ; Seddon AN; Ogunniyi A; King AC; Buie LW; Daley RJ Ann Pharmacother; 2018 Mar; 52(3):268-276. PubMed ID: 29025266 [TBL] [Abstract][Full Text] [Related]
17. Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives. Franca R; Favretto D; Granzotto M; Decorti G; Rabusin M; Stocco G Curr Med Chem; 2017; 24(11):1050-1065. PubMed ID: 28088906 [TBL] [Abstract][Full Text] [Related]